Strides Shasun gets USFDA’s nod for Memantine Hydrochloride Tablets

24 May 2017 Evaluate

Strides Shasun has received approval from the United States Food & Drug Administration (USFDA) for Memantine Hydrochloride Tablets USP, 5 mg and 10 mg. Memantine Hydrochloride Tablets are indicated for the treatment of moderate to severe Alzheimer-type dementia

The US market for Memantine Hydrochloride Tablets USP, 5 mg and 10 mg is around $60 million. The product will be manufactured at the company’s flagship facility at Bangalore and marketed by Strides Pharma Inc in the US Market. The product will be launched immediately.

Strides Shasun (formerly known as Strides Arcolab) is engaged in manufacturing, sale and export of pharmaceutical products. It offers general tablets, hard gelatin and soft gelatin capsules, sachets, potent drugs and semi-solids.

Strides Pharma Scien Share Price

937.75 -1.65 (-0.18%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×